Protective effects of amlodipine and lacidipine on ovariectomy-induced bone loss in rats

European Journal of Pharmacology

Volumn 579, Issue 1-3, 2008, Pages 241-245

  Halici, Zekai ^a   Borekci, Bunyamin ^a   Ozdemir, Yuksel ^b   Cadirci, Elif ^a   Suleyman, Halis ^a  

^a ATATURK UNIVERSITY   (Turkey)

^b ATATÜRK UNIVERSITY   (Turkey)

Author keywords

(Rat); Amlodipine; Bone; Calcium; Lacidipine; Osteoporosis

Indexed keywords

AMLODIPINE; AMLODIPINE BESYLATE; CALCIUM; LACIDIPINE; PHOSPHORUS; THIOPENTAL;

ANIMAL EXPERIMENT; ARTICLE; BONE METABOLISM; CALCIUM BONE LEVEL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FEMUR; NONHUMAN; OSTEOLYSIS; OSTEOPENIA; OVARIECTOMY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE;

AMLODIPINE; ANIMALS; BONE AND BONES; CALCIUM; CALCIUM CHANNEL BLOCKERS; DIHYDROPYRIDINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FEMUR; OSTEOPOROSIS; OVARIECTOMY; PHOSPHORUS; RATS; RATS, WISTAR; SPECTROMETRY, X-RAY EMISSION;

EID: 37549049042     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.09.027     Document Type: Article

References (33)

1. Anke C.R., Heinrich L., Thomas B., Reinhard B., and Renate R. Endothelial antioxidant actions of dihydropyridines and angiotensin converting enzyme inhibitors. Eur. J. Pharmacol. 529 (2006) 55-62
2. Barlet J.P., Coxam V., Davicco M.J., and Gaumet N. Animal models of postmenopausal osteoporosis. Reprod. Nutr. Dev. 34 (1994) 221-236
3. 2+. Endocrinology 129 (1991) 2993-3000
4. Caffrey J.M., and Farach-Carson M.C. Vitamin D3 metabolites modulate dihydropyridine-sensitive calcium currents in clonal rat osteosarcoma cells. J. Biol. Chem. 264 (1989) 20265-20274
5. Cappuccio F.P., Meilahn E., Zmuda J.M., and Cauley J.A. High blood pressure and bone-mineral loss in elderly white women: a prospective study. Study of Osteoporotic Fractures Research Group. Lancet 354 (1999) 971-975
6. Chestnut III C.H. Drug therapy: calcitonin, bisphosphonates, and anabolic steroids. In: Riggs B.L., and Melton III L.J. (Eds). Osteoporosis: Etiology, Diagnosis, and Management (1995), Lippincott-Raven Publishers, Philadelphia, MA 391
7. Civantos B., and Aleixandre A. Blood pressure and α-vascular reactivity in hypertensive rats treated with amlodipine and dietary Ca. Eur. J. Pharmacol. 489 (2004) 101-110
8. Duncan R.L., Akanbi K.A., and Farach-Carson M.C. Calcium signals and calcium channels in osteoblastic cells. Semin. Nephrol. 18 (1988) 178-190
9. Gu Y., Preston M.R., Magnay J., El Haj A.J., and Publicover S.J. Hormonally-regulated expression of voltage-operated Ca2+ channels in osteocytic (MLO-Y4) cells. Biochem. Biophys. Res. Commun. 282 (2001) 536-542
10. Guggino S.E., Lajeunesse D., Wagner J.A., and Snyder S.H. Bone remodeling signalled by a dihydropyridine- and phenylalkylamine-sensitive calcium channel. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 2957-2960
11. Izawa Y., Sagara K., Kadota T., and Makita T. Bone disorders in spontaneously hypertensive rat. Calcif. Tissue Int. 37 (1985) 605-607
12. Kalu D.N. The ovariectomized rat model of postmenopausal bone loss. Bone Miner. 15 (1991) 175-191
13. Kataoka C., Egashira K., Ishibashi M., Inoue S., Ni W., Hiasa K., Kitamoto S., Usui M., and Takeshita A. Novel anti-inflammatory actions of amlodipine in a rat model of arteriosclerosis induced by long-term inhibition of nitric oxide synthesis. Am. J. Physiol, Heart Circ. Physiol. 286 (2004) 768-774
14. Kurihara N., Ishizuka S., Kiyoki M., Haketa Y., Ikeda K., and Kumegawa M. Effects of 1,25-dihydroxyvitamin D3 on osteoblastic MC3T3-E1 cells. Endocrinology 118 (1986) 940-947
15. Kyoko T., Shinji F., Takaya I., Kazutoshi N., Satoshi K., and Koichiro T. Incadronate inhibits osteoporosis in ovariectomized rats. Eur. J. Pharmacol. 457 (2002) 51-56
16. Lieberherr M. Effects of vitamin D3 metabolites on cytosolic free calcium in confluent mouse osteoblasts. J. Biol. Chem. 262 (1987) 13168-13173
17. Mason R.P., Walter M.F., Trumbore M.W., Olmstead Jr. E.G., and Mason P.E. Membrane antioxidant effects of the charged dihydropyridine calcium antagonist amlodipine. J. Mol. Cell. Cardiol. 31 (1999) 275-281
18. McCarron D.A., Pingree P.A., Rubin R.J., Gaucher S.M., Molitch M., and Krutzik S. Enhanced parathyroid function in essential hypertension: a homeostatic response to a urinary calcium leak. Hypertension 2 (1980) 162-168
19. Morain P., Peglion J.L., and Giesen-Crouse E. Ca2+ channel inhibition in a rat osteoblast-like cell line, UMR 106, by a new dihydropyridine derivative, S11568. Eur. J. Pharmacol. 220 (1992) 11-17
20. Moreau R., Hurst A.M., Lapointe J.Y., and Lajeunesse D. Activation of maxi-K channels by parathyroid hormone and prostaglandin E2 in human osteoblast bone cells. J. Membr. Biol. 150 (1996) 175-184
21. Nakatani Y., Tsunoi M., Hakeda Y., Kurihara N., Fujita K., and Kumegawa M. Effects of parathyroid hormone on cAMP production and alkaline phosphatase activity in osteoblastic clone MC3T3-E1 cells. Biochem. Biophys. Res. Commun. 123 (1986) 894-898
22. Nishiya Y., and Sugimoto S. Effects of various antihypertensive drugs on the function of osteoblast. Biol. Pharm. Bull. 24 (2001) 628-633
23. Nishiya Y., Kosaka N., Uchii M., and Sugimoto S. A potent 1,4-dihydropyridine L-type calcium channel blocker, benidipine, promotes osteoblast differentiation. Calcif. Tissue Int. 70 (2002) 30-39
24. Notoya M., Arai R., Katafuchi T., Minamino N., and Hagiwara H. A novel member of the calcitonin gene-related peptide family, calcitonin receptor-stimulating peptide, inhibits the formation and activity of osteoclasts. Eur. J. Pharmacol. 560 (2007) 234-239
25. Pitt B., Byington R.P., Furberg C.D., Hunninghake D.B., Mancini G.B., Miller M.E., and Riley W. PREVENT Investigators: effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. Circulation 102 (2000) 1503-1510
26. Shuichi T., Michis W., Hisashi Y., and Akio F. Chronopharmacology of oxacalcitriol in rat model of osteoporosis. Eur. J. Pharmacol. 488 (2004) 239-245
27. Strazzullo P., Nunziata V., Cirillo M., Giannattasio R., Ferrara L.A., Mattioli P.L., and Mancini M. Abnormalities of calcium metabolism in essential hypertension. Clin. Sci. 65 (1983) 137-141
28. Tanaka H., Shoji Y., Ogami T., Ogura K., Kosaka N., Seo H., Nakamura J., and Shuto K. The effect of benidipine hydrochloride on the bones of male spontaneously hypertensive rats. J. New Rem. Clin. 42 (1993) 55-66
29. Tsien R.W., Ellinor P.T., Zhang J.F., and Bezprozvanny I. Molecular biology of calcium channels and structural determinants of key functions. J. Cardiovasc. Pharmacol. 27 (1996) 4-10
30. Wronski T.J., Cintron M., and Dann L.M. Temporal relationship between bone loss and increased bone turnover in ovariectomized rats. Calcif. Tissue Int. 43 (1998) 179-183
31. Zahanich I., Graf E.M., Heubach J.F., Hempel U., Boxberger S., and Ravens U. Molecular and functional expression of voltage-operated calcium channels during osteogenic differentiation of human mesenchymal stem cells. J. Bone Miner. Res. 20 (2005) 1637-1646
32. Zhang X., and Hintze T.H. Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent. Circulation 97 (1998) 576-580
33. Zhang Y., Yu L., Ao M., and Jin W. Effect of ethanol extract of Lepidium meyenii Walp. on osteoporosis in ovariectomized rat. J. Ethnopharmacol. 21 (2006) 274-279